AMERICAN SHARED HOSPITAL SERVICES Proceeds from Insurance Settlement, Investing Activities
AMERICAN SHARED HOSPITAL SERVICES (AMS) reported Proceeds from Insurance Settlement, Investing Activities of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-04-03.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromInsuranceSettlementInvestingActivities · last filed 2020-04-03
- AMERICAN SHARED HOSPITAL SERVICES proceeds from insurance settlement, investing activities for the quarter ending 2019-12-31 was -$160.00K, a 413.73% decline year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES proceeds from insurance settlement, investing activities for the quarter ending 2019-09-30 was $0.00.
- AMERICAN SHARED HOSPITAL SERVICES proceeds from insurance settlement, investing activities for the quarter ending 2019-06-30 was $0.00.
- AMERICAN SHARED HOSPITAL SERVICES proceeds from insurance settlement, investing activities for the quarter ending 2019-03-31 was $160.00K.
- AMERICAN SHARED HOSPITAL SERVICES proceeds from insurance settlement, investing activities for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- AMERICAN SHARED HOSPITAL SERVICES proceeds from insurance settlement, investing activities for fiscal 2018 was $51.00K.
- AMERICAN SHARED HOSPITAL SERVICES proceeds from insurance settlement, investing activities for fiscal 2017 was $0.00.
- AMERICAN SHARED HOSPITAL SERVICES proceeds from insurance settlement, investing activities for fiscal 2016 was $0.00.
| Period end | Proceeds from Insurance Settlement, Investing Activities 3 month | Proceeds from Insurance Settlement, Investing Activities 6 month | Proceeds from Insurance Settlement, Investing Activities 9 month | Proceeds from Insurance Settlement, Investing Activities 12 month |
|---|---|---|---|---|
| 2019-12-31 | -$160.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-03 | -$160.00K derived: sum of 2 quarters · filed 2020-04-03 | -$160.00K derived: sum of 3 quarters · filed 2020-04-03 | $0.00 10-K · filed 2020-04-03 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $0.00 derived: sum of 2 quarters · filed 2019-11-07 | $160.00K 10-Q · filed 2019-11-07 | $211.00K derived: sum of 4 quarters · filed 2020-04-03 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $160.00K 10-Q · filed 2019-08-13 | $211.00K derived: sum of 3 quarters · filed 2020-04-03 | $211.00K derived: sum of 4 quarters · filed 2020-04-03 |
| 2019-03-31 | $160.00K 10-Q · filed 2019-05-13 | $211.00K derived: sum of 2 quarters · filed 2020-04-03 | $211.00K derived: sum of 3 quarters · filed 2020-04-03 | $211.00K derived: sum of 4 quarters · filed 2020-04-03 |
| 2018-12-31 | $51.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-03 | $51.00K derived: sum of 2 quarters · filed 2020-04-03 | $51.00K derived: sum of 3 quarters · filed 2020-04-03 | $51.00K 10-K · filed 2020-04-03 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $0.00 derived: sum of 2 quarters · filed 2019-11-07 | $0.00 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $0.00 10-Q · filed 2019-08-13 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-13 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-04-03 | |||
| 2016-12-31 | $0.00 10-K · filed 2019-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |